Biochemistry, Genetics and Molecular Biology
Induced Pluripotent Stem Cell
75%
Bone Marrow Failure
66%
Genome Editing
50%
GATA2
50%
Stem Cell
50%
FANCB
50%
Progenitor Cell
46%
Peripheral Blood Cell
31%
Natural Killer Cell
30%
Cross-Link
29%
DNA Repair
29%
FANCD2
28%
Myeloid
27%
Fibroblast
27%
Stable Expression
25%
Mosaicism
25%
Genomic Signature
25%
Transgene
25%
Genome Instability
25%
Germ Layer
25%
Epigenetics
19%
Crosslinking of DNA
18%
Germline Mutation
18%
Genome Editing
18%
Allele
15%
Hematopoietic Stem Cell
14%
Genetics
12%
Reprogramming
12%
Genome Sequencing
12%
Complex Formation
12%
Exome Sequencing
12%
Keratinocyte
12%
Missense
12%
Virus DNA Cell DNA Interaction
12%
Mesenchymal-Epithelial Transition
12%
Adeno Associated Virus
12%
Aldehyde Dehydrogenase
12%
Carcinogenesis
12%
Wild Type
12%
Ubiquitination
11%
CRISPR/Cas9
10%
Maturation
8%
Precursor
7%
Somatic Mutation
6%
Exon
6%
Ribosome Biogenesis
6%
Diamond-Blackfan Anemia
6%
Genotyping
6%
Hemocyte
6%
Shwachman-Diamond Syndrome
6%
Keyphrases
Fanconi Anemia
100%
Induced Pluripotent Stem Cells (iPSCs)
50%
Bone Marrow Failure
33%
In Cancer
29%
Rhesus
25%
Differentiated Cells
25%
Stable Expression
25%
Gene Editing
25%
Somatic Transformation
25%
Human Bone Marrow
25%
DNA Repair Pathways
25%
Safe Harbor
25%
Clinical Phenotype
25%
Surgical Abdomen
25%
FANCD2 Monoubiquitination
25%
Genomic Signature
25%
Stem Cell Engineering
25%
SAMD9
25%
Genetic Engineering
25%
Transcriptional Repression
25%
Pluripotent Stem Cells
25%
Acute Myeloid Leukemia
25%
Aldehyde Dehydrogenase 2 (ALDH2)
25%
Germ Layers
25%
FANCB
25%
Clinical Severity
25%
Genome Editing
18%
Cell-based
14%
Squamous Cell
14%
Integration Site
12%
Hematopoietic Stem Cells
12%
Clinically Significant
12%
Virus Integration
12%
Missense Variants
12%
Adenovirus
12%
Hematological Diseases
10%
DNA Interstrand Crosslinks
8%
Nonhuman Primate
8%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
8%
Ubiquitination
8%
Genetic Disease
6%
Kidney Disease
6%
Healthy Individuals
6%
Neutrophil Maturation
6%
Patient Materials
6%
FANC Genes
6%
Inherited Bone Marrow Failure
6%
Developmental Defects
6%
Clinical Outcomes
6%
Cas9 Protein
6%
Medicine and Dentistry
Disease
51%
Bone Marrow Failure
50%
B-Cell Chronic Lymphocytic Leukemia
50%
Marrow Failure Syndrome
37%
Progenitor Cell
37%
Angioedema
30%
Transcription Factor GATA 2
25%
Pluripotent Stem Cell
25%
Natural Killer Cell
25%
Genome Engineering
25%
Fanconi Anemia
25%
Stem Cell
25%
Induced Pluripotent Stem Cell
20%
Genome Editing
15%
Myelodysplastic Syndrome
14%
Monosomy 7
12%
Allele
12%
Hyperactivation
12%
Abdominal Pain
12%
Hematopoietic Stem Cell
11%
Prophylaxis
6%
Bowel Resection
6%
Lymphoproliferative Disease
6%
Symptom
6%
Disease Course
6%
Genetic Disorder
6%
Microcephaly
6%
Phenotypic Variation
6%
Combination Therapy
6%
Germline Mutation
5%
Awareness
5%
Somatic Mutation
5%
Von Willebrand Disease
5%
Target Tissue
5%
Leukemia Remission
5%
Early Diagnosis
5%
Myasthenia gravis
5%
Cas9
5%
Bullous Pemphigoid
5%
Clustered Regularly Interspaced Short Palindromic Repeat
5%
Sulfhemoglobinemia
5%
Blood Cell
5%
Idiopathic Thrombocytopenic Purpura
5%
Evans Syndrome
5%
Recrudescence
5%
